Search Results

Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.

• Authors : Abdulaal, Marwan; Donkor, Richard; Robertson, Jacobi

• Source: Canadian Journal of Ophthalmology; Oct2024, Vol. 59 Issue 5, pe582-e589, 8p

Record details

Improved outcome with individualised antifibrinolytic therapy: what is the evidence?

• Authors : Bolliger, Daniel¹ (AUTHOR) ; Ranucci, Marco² (AUTHOR)

Subjects: *TISSUE plasminogen activator; *TRANEXAMIC acid; *CARDIAC surgery

• Source: BJA: The British Journal of Anaesthesia. Jun2024, Vol. 132 Issue 6, p1187-1189. 3p.

Record details

Tenecteplase in Pediatric Stroke: Ready or Not.

• Authors : Wilson, Jenny L.¹ (AUTHOR) ; Waak, Michaela² (AUTHOR); Barry, Megan³ (AUTHOR)

Subjects: *TISSUE plasminogen activator; *CHILDREN'S hospitals

• Source: Pediatric Neurology. Feb2024, Vol. 151, p17-20. 4p.

Record details

Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity.

• Authors : Li, Siyuan¹ (AUTHOR); Atkinson, Helen M.^2,3 (AUTHOR); Fusch, Gerhard² (AUTHOR)

Subjects: *TISSUE plasminogen activator; *FIBRINOLYTIC agents; *ANTICOAGULANTS

• Source: Biomaterials Advances. Jan2025, Vol. 166, pN.PAG-N.PAG. 1p.

Record details

Preparation and in vitro evaluation of tissue plasminogen activator-loaded nanoliposomes with anticoagulant coating.

• Authors : Ahmaditabar, Parvin¹ (AUTHOR); Mahmoodi, Mahboobeh^1,2,3 (AUTHOR) ; Taheri, Ramezan Ali⁴ (AUTHOR)

Subjects: *TISSUE plasminogen activator; *GLASS transition temperature; *THROMBOSIS

• Source: BBA - General Subjects. Nov2024, Vol. 1868 Issue 11, pN.PAG-N.PAG. 1p.

Record details

Intraventricular Tissue Plasminogen Activator and Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage.

• Authors : Pacult, Mark A.¹ (AUTHOR); Catapano, Joshua S.¹ (AUTHOR); Rumalla, Kavelin¹ (AUTHOR)

Subjects: *TISSUE plasminogen activator; *SUBARACHNOID hemorrhage

• Source: World Neurosurgery. Feb2023, Vol. 170, p242-243. 2p.

Record details

The changes of tPA/PAI-1 system are associated with the ratio of BDNF/proBDNF in major depressive disorder and SSRIs antidepressant treatment.

• Authors : Yang, Zhilan¹ (AUTHOR); Gao, Changqing¹ (AUTHOR); Li, Zhipeng¹ (AUTHOR)

Subjects: *TISSUE plasminogen activator; *BRAIN-derived neurotrophic factor; *MENTAL depression

• Source: Neuroscience. Nov2024, Vol. 559, p220-228. 9p.

Record details

Corrigendum to "Tissue plasminogen activator for acute branch atheromatous disease exhibits transient improvement and worsening" [Journal of the Neurological Sciences Volume 465 (2024) 123201].

• Authors : Kobayashi, Yuya^1,2 (AUTHOR) ; Kondo, Yasufumi² (AUTHOR); Yamamoto, Kanji² (AUTHOR)

Subjects: *TISSUE plasminogen activator; *NEUROSCIENCES

• Source: Journal of the Neurological Sciences. Nov2024, Vol. 466, pN.PAG-N.PAG. 1p.

Record details

Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial.

• Authors : Rashidi, Farid¹ (AUTHOR) ; Barco, Stefano^2,3 (AUTHOR); Rezaeifar, Parisa¹ (AUTHOR)

Subjects: *TISSUE plasminogen activator; *THROMBOLYTIC therapy; *COVID-19

• Source: Thrombosis Research. Aug2022, Vol. 216, p125-128. 4p.

Record details

Tissue plasminogen activator for acute branch atheromatous disease exhibits transient improvement and worsening.

• Authors : Kobayashi, Yuya^1,2 (AUTHOR) ; Kondo, Yasufumi² (AUTHOR); Yamamoto, Kanji² (AUTHOR)

Subjects: *TISSUE plasminogen activator; *ISCHEMIC stroke; *STROKE

• Source: Journal of the Neurological Sciences. Oct2024, Vol. 465, pN.PAG-N.PAG. 1p.

Record details